findmyKOL
Clinical trialNCT02558829CompletedPhase 3Interventional

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

SponsorAEterna ZentarisEnrollment157Growth Hormone Deficiency With Pituitary Anomalies
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Krankenanstalt Rudolfstiftung

    Vienna, Austria

  • Medical University & General Hospital of Vienna, Akh,

    Vienna, Austria

France
  • Chu de Lyon Hcl-Gh Est

    Bron, France

  • Ghu Paris-Sud - Hôpital de Bicêtre

    Le Kremlin-Bicêtre, France

  • Hôpital Haut-Lévêque

    Pessac, France

Germany
  • Klinikum Der Lmu München

    Munich, Bavaria, Germany

  • Max Planck Institut

    Munich, Bavaria, Germany

  • University Hospital Marburg

    Marburg, Hesse, Germany

  • Rwth Aachen University Hospital

    Aachen, North Rhine-Westphalia, Germany

  • Klinik Für Endokrinologie, Diabetes Und Ernährungsmedizin Der Charité

    Berlin, Germany

Italy
  • San Luca Hospital

    Milan, Italy

Poland
  • Centrum Kliniczno-Badawcze

    Elblag, Poland

  • Centrum Medyczne Angelius Provita

    Katowice, Poland

  • Phase I - Mtz Clinical Research Sp. Z O.O.

    Warsaw, Poland

  • Wromedica

    Wroclaw, Poland

Serbia
  • Clinical Centre of Serbia

    Belgrade, Serbia

  • Clinical Centre of Vojvodina

    Novi Sad, Serbia

Spain
  • Hospital Universitari Vall D' Hebron

    Barcelona, Spain

  • Hospital de Sant Pau

    Barcelona, Spain

  • Hospital de Conxo

    Santiago de Compostela, Spain

United Kingdom
  • St Bartholomew'S Hospital

    London, United Kingdom

  • the Christie Nhs Foundation Trust

    Manchester, United Kingdom

United States
  • Harbor Ucla Medical Center

    Torrance, California, United States

  • Texas Diabetes and Endocrinology

    Austin, Texas, United States

  • Baylor College of Medicine-Endocrinology

    Houston, Texas, United States

  • Swedish Medical Center - Cherry Hill

    Seattle, Washington, United States

  • Va Puget Sound Health Care System

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Dec 2015
Primary completion
29 Nov 2016
Completion
29 Nov 2016
Last update posted
10 Apr 2018
Registered enrollment
157
Registry id
NCT02558829

Cross-registrations

EU-CTR / CTIS (EudraCT)2015-002337-22

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.